Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cellular Therapy in NSCLC: Between Myth and Reality.
Imbimbo M, Wetterwald L, Friedlaender A, Parikh K, Addeo A. Imbimbo M, et al. Among authors: addeo a. Curr Oncol Rep. 2023 Oct;25(10):1161-1174. doi: 10.1007/s11912-023-01443-z. Epub 2023 Aug 30. Curr Oncol Rep. 2023. PMID: 37646900 Free PMC article. Review.
New emerging targets in cancer immunotherapy: the role of TIM3.
Friedlaender A, Addeo A, Banna G. Friedlaender A, et al. Among authors: addeo a. ESMO Open. 2019 Jun 12;4(Suppl 3):e000497. doi: 10.1136/esmoopen-2019-000497. eCollection 2019. ESMO Open. 2019. PMID: 31275616 Free PMC article. Review.
Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLC.
Friedlaender A, Banna G, Patel S, Addeo A. Friedlaender A, et al. Among authors: addeo a. Curr Treat Options Oncol. 2019 Sep 4;20(10):79. doi: 10.1007/s11864-019-0675-9. Curr Treat Options Oncol. 2019. PMID: 31482479 Review.
220 results